Avience Biomedicals Limited SME IPO: Price, GMP, Dates & Review

By /
Avience Biomedicals Limited IPO
AB
Avience Biomedicals Limited IPO
Molecular Diagnostic Solutions · Medical Devices & Analyzers · Noida Manufacturing Unit · B2B & B2G Markets
📋 SME IPO Fresh Issue NSE SME
₹208
Upper Price
₹30.24 Cr
Issue Size
Jun 25, 2026
Listing Date
₹114.09 Cr
Market Cap
📋 IPO Timetable
All dates tentative
🟢
IPO Opens
Thursday, 18 June 2026
Bidding starts — apply before close
🔒
IPO Closes
Monday, 22 June 2026
Last day to bid — closes at 5:00 PM IST
📊
Tuesday, 23 June 2026
Allotment finalised by registrar
🔄
Wednesday, 24 June 2026
Unallotted funds returned; shares credited to demat
🏷️
Thursday, 25 June 2026
Trading begins from 10:00 AM IST
📋 IPO Details
IPO Open Date18 June 2026 (Thu)
IPO Close Date22 June 2026 (Mon)
Listing Date25 June 2026 (Thu)
Face Value₹10 per share
Price Band₹196 to ₹208
Issue Price (Upper Band)₹208 per share
Issue TypeBook Build — Fresh Issue
Lot Size600 shares
Total Issue Size14,53,800 shares (₹30.24 Cr)
Fresh Issue14,53,800 shares (₹30.24 Cr)
Market Maker Shares82,200 shares (₹2 Cr)
Pre-Issue Shares40,31,256
Post-Issue Shares54,85,056
Promoter Holding (Pre)87.89%
Lead ManagerFintellectual Corporate Advisors Pvt.Ltd.
RegistrarSkyline Financial Services Pvt.Ltd.
💰 Lot Size & Minimum Investment
At upper price ₹208
Investor TypeLotsSharesAmount
Retail — Minimum & Maximum21,200₹2,49,600
S-HNI (sNII) — Min31,800₹3,74,400
S-HNI (sNII) — Max84,800₹9,98,400
B-HNI (bNII) — Min95,400₹11,23,200
⚠️ SME IPO Note: Minimum application for retail is 2 lots (1,200 shares = ₹2,49,600). Retail maximum limit is also 2 lots. Lot size is 600 shares; bids must be in multiples thereof.
👥 Investor Reservation
Total 14,53,800 shares
49.83%
QIB Portion
6,83,400 shares
35.08%
Retail (RII)
4,81,200 shares
15.09%
NII / HNI
2,07,000 shares
💡 Quota Highlights: Anchor Investor portion included in QIB allocation is 4,09,800 shares (28.19%). The Market Maker allocation stands firm at 82,200 shares (5.65%).
📊 Live Subscription Status
Awaiting Bidding
Subscription data will be available once bidding begins on June 18, 2026. Check back for live updates from 10:00 AM IST.
📈 Company Financials
Restated Consolidated · ₹ Crore
Metric31 Jan 202631 Mar 202531 Mar 2024
Total Assets66.0756.5234.65
Total Income41.9445.9724.37
PAT5.747.232.14
EBITDA10.3411.414.08
Net Worth28.5222.786.21
Total Borrowing26.7322.1615.13
Income Growth
FY 2024–25₹45.97 Cr
10M FY26 (Jan 2026)₹41.94 Cr
🎯 Key Performance Indicators
50.14%
ROE
FY 2024–25
24.84%
ROCE
FY 2024–25
49.89%
RoNW
FY 2024–25
0.97
Debt/Equity
FY 2024–25
22.38%
ROE (10M)
Jan 31, 2026
16.99%
ROCE (10M)
Jan 31, 2026
15.86%
PAT Margin
Jan 31, 2026
2.94x
Price/Book
Jan 31, 2026
⚖️ Valuation & EPS
Pre-IPO EPS
₹17.94
FY25 earnings / pre-issue shares
P/E: 11.59x
Post-IPO EPS
₹12.56
Annualised 10M FY26 / post-issue shares
P/E: 16.56x
Price to Book Value
3.68x
At upper price band (FY25 book)
Market Cap (Post-IPO)
₹114.09 Cr
At upper price band ₹208
ℹ️ Pre-IPO EPS (₹17.94) based on pre-issue shareholding (40,31,256). Post-IPO EPS (₹12.56) based on post-issue shareholding (54,85,056) and annualised Jan 2026 earnings.
🎯 Objects of the Issue
Net proceeds utilisation
1
Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
₹15.96 Cr
2
Funding the working capital requirements of the Company
₹8.25 Cr
Total Net Proceeds Target ₹24.21 Cr
🏢 About Avience Biomedicals Limited
Est. 2024 · Noida, Uttar Pradesh · Diagnostics & Medical Devices

Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.

The company has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets. Its products cater to pathology labs, microbiology labs, hospitals, and research centers nationwide as well as overseas from its manufacturing unit in Noida, Uttar Pradesh.

Competitive Strengths
✅Strong industry experience and technical expertise
📍Comprehensive product range: rapid test kits, analyzers, hematology devices, and molecular kits
📋Strong distribution network across India with expanding global footprint
👨‍💼Cost-effective, affordable solutions supported by stringent quality control and regulatory compliance
Company Promoters
DC
Mr. Dharam Deo Choudhary
Promoter, Avience Biomedicals Limited
RC
Mr. Ram Nagina Choudhary
Promoter, Avience Biomedicals Limited
📅 Key Dates
IPO Opens18 June 2026
IPO Closes22 June 2026
Allotment23 June 2026
Refund & Share Credit24 June 2026
Listing Day25 June 2026
Price Band₹196 – ₹208
Issue Price₹208 / share
Lot Size600 shares
Min. Investment (Retail)₹2,49,600 (2 lots)
Issue Size₹30.24 Cr
Listing PlatformNSE SME
Registrar
Skyline Financial Services Pvt.Ltd.
📞 02228511022
[email protected]
Lead Manager
Fintellectual Corporate Advisors Pvt.Ltd.
Market Maker
Asnani Stock Broker Pvt.Ltd.
Avience Biomedicals Ltd.
C-11, Block-C, Community Centre,
Janakpuri A-3, Delhi, New Delhi — 110058
📞 1800-12-04-636
[email protected]
🛡️ Regulatory Note: SME IPO investments are subject to SEBI regulations. Always read the Prospectus/RHP before applying. Consult a SEBI-registered advisor before investing.
⚠️ Disclaimer: This page presents publicly available information from the Avience Biomedicals IPO RHP for informational purposes only. It does not constitute investment advice. IPO investments are subject to market risk. Please read all offer documents and consult a SEBI-registered advisor before investing.
📊
Track Avience Biomedicals Limited SME IPO: Price, GMP, Dates & Review GMP
Check real-time grey market premium, daily GMP history & estimated listing price.
Check GMP →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top